Spago Nanomedical select CTC for the first clinical trial with SpagoPix
Spago Nanomedical AB has signed an agreement with the Swedish clinical CRO CTC Clinical Trial Consultants AB for the conduct of the first clinical study with SpagoPix.The aim of the clinical trial is to document safety and MR images in cancer patients. Compilation of clinical study protocol and material for the application for clinical trial with the Swedish Medical Products Agency is in progress. The study will include approximately 20 cancer patients and be conducted at a small number of centers. ”Following on the recently communicated positive preclinical results the agreement with